Evaluating body composition of Italian prostate cancer patients without metastases

被引:19
作者
Maturo, G
Vespasiani, G
Mohamed, EI
Maiolo, C
Agrò, EF
Forte, F
De Lorenzo, A
机构
[1] Univ Roma Tor Vergata, Policlin Casilino, Div Urol, I-00169 Rome, Italy
[2] Univ Roma Tor Vergata, Fac Med & Surg, Div Urol, Rome, Italy
[3] Univ Roma Tor Vergata, Fac Med & Surg, Div Human Nutr, Rome, Italy
[4] Univ Alexandria, Med Res Inst, Dept Biophys, Alexandria, Egypt
[5] Casa Cura Nova Salus Srl, Laquila, Italy
关键词
prostate cancer; body composition; dual X-ray absorptiometry; bone mineral density; bioelectric impedance analysis (BIA); water compartment;
D O I
10.1007/s00592-003-0056-4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Prostate cancer (PCa) is becoming an increasingly important public health problem worldwide, and anthropometric studies have revealed that body composition is a potential risk factor for this type of cancer. The objective of the present study was to compare Italians with PCa and no history of androgen deprivation therapy or bone metastases with healthy controls in terms of body composition. We recruited 11 PCa patients [mean age (+/-SD), 68.67+/-4.93 years; body mass index (BMI), 28.42+/-2.96 kg/m(2)] and 11 healthy controls matched for age and BMI. Anthropometric and body composition parameters were measured for all participants using dual X-ray absorptiometry and bioelectric impedance analysis techniques. We found that lean body mass, but not fat mass, was significantly lower for PCa patients in comparison with healthy controls (50.24+/-5.03 vs. 53.63+/-5.61 kg, p<0.05). Thus, PCa patients with no history of androgen deprivation therapy and no bone metastasis suffer muscle mass depletion.
引用
收藏
页码:S168 / S170
页数:3
相关论文
共 11 条
[1]
Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy [J].
Berruti, A ;
Dogliotti, L ;
Terrone, C ;
Cerutti, S ;
Isaia, G ;
Tarabuzzi, R ;
Reimondo, G ;
Mari, M ;
Ardissone, P ;
De Luca, S ;
Fasolis, G ;
Fontana, D ;
Rossetti, SR ;
Angeli, A .
JOURNAL OF UROLOGY, 2002, 167 (06) :2361-2367
[2]
BLAIR A, 1978, J NATL CANCER I, V61, P1379
[3]
Chang S, 2001, PROSTATE, V46, P62
[4]
Anthropometric risk factors for prostate cancer [J].
DemarkWahnefried, W ;
Conaway, MR ;
Robertson, CN ;
Mathias, BJ ;
Anderson, EE ;
Paulson, DF .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1997, 28 (03) :302-307
[5]
Cancer statistics, 1997 [J].
Parker, SL ;
Tong, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (01) :5-27
[6]
Schuurman AG, 2000, AM J EPIDEMIOL, V151, P541, DOI 10.1093/oxfordjournals.aje.a010241
[7]
CANCERS OF THE PROSTATE AND BREAST AMONG JAPANESE AND WHITE IMMIGRANTS IN LOS-ANGELES-COUNTY [J].
SHIMIZU, H ;
ROSS, RK ;
BERNSTEIN, L ;
YATANI, R ;
HENDERSON, BE ;
MACK, TM .
BRITISH JOURNAL OF CANCER, 1991, 63 (06) :963-966
[8]
Smith MR, 2001, CANCER-AM CANCER SOC, V91, P2238
[9]
Measurement of body fat by dual-energy x-ray absorptiometry and bioimpedance analysis in men with prostate cancer [J].
Smith, MR ;
Fuchs, V ;
Anderson, EJ ;
Fallon, MA ;
Manola, J .
NUTRITION, 2002, 18 (7-8) :574-577
[10]
STELLMAN SD, 1994, CANCER, V73, P1257